author-photo

Anthony Sabulski

New York Medical College

3

Papers

65

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20(+) BL and pre-B-ALL.

2015 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (64)
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) vs Peripheral Blood (PB) CD56+dim NK Cells: A More Pro NK Phenotype in CB

2013 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Obinutuzumab (GA101) Significantly Enhances Cell Death and ADCC Compared to Rituximab Against CD20+ sensitive and Rituximab Resistant B-Cell Non-Hodgkin Lymphoma (NHL) and Lymphoblastic Leukemia (BLL)

2012 Blood
Show All
- Source
- Cite
- Save
Citations (1)